AAAli Alkhoshaiban

Ali Alkhoshaiban

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Alkhoshaiban has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Assessment of Knowledge, Attitude, and Practice (KAP) of Colorectal Cancer among Community Pharmacists in the Qassim Region of Saudi Arabia

    by Mohammed Alshammari, Saleh Al-Maktoum, Abdulrahman Alsharidah, Abubakar Siddique, Mohammed Anaam, Saud Alsahali, Yasser Almogbel, Ali Alkhoshaiban

    Background: The global burden of colorectal cancer remains a major public health issue and one of the leading causes of death worldwide. In Saudi Arabia, it continues to be a health concern. Any delays in diagnosis for any reason may contribute to advanced complications; therefore, pharmacists’ knowledge and awareness of colorectal cancer are crucial for the welfare of society. Studies of colon cancer-related knowledge, attitude, and practice (KAP) among community pharmacists have not previously been conducted in the Al-Qassim region of Saudi Arabia. In the present study, therefore, we sought to investigate the KAP on colon cancer among pharmacists in Al-Qassim. Methods: This was a prospective, cross-sectional, observational study. A sample of 150 community pharmacists was recruited using a convenience sampling method. A self-administered questionnaire was used to evaluate levels of knowledge and practice. Results: Out of a total of 150 pharmacists, the majority of respondents (60.7%) possessed an adequate level of knowledge. About 50% of participants had heard of the early screening test, and 68.7% knew that colonoscopy is necessary in such scenarios. On the basis of their attitudes, 41.3% of study participants were aware of colon cancer symptoms and risk factors. In practice, however, the majority of pharmacists (81%) did not perform early cancer screenings, while 19% did screen when advised to do so by a physician. Conclusions: Our results indicate that pharmacists in Qassim have an adequate level of knowledge of colon cancer in terms of awareness, assessment, and screening. Since community pharmacists are among the most reliable members of the medical community, a greater awareness of colon cancer among pharmacists may improve public knowledge of the disease.


  • Open Access

    Therapeutic Targeting of MOAP-1 in Cancer: A Systematic Review of Current Approaches and Future Directions

    by Xinwei Koong, Keyun Look, Amar Daud Iskandar Abdullah, Kuan Onn Tan, Vasudevan Mani, Hooi-Leng Ser, Khang Wen Goh, Ali Saleh Alkhoshaiban, Long Chiau Ming

    The Modulator of Apoptosis 1 (MOAP-1) protein, a crucial regulator of apoptosis, has recently attracted considerable interest in oncology research. Its potential as a therapeutic target in bladder, breast, and non-small cell lung cancer (NSCLC) offers intriguing new therapeutic approaches. This comprehensive review consolidated work on MOAP-1's role in cancer biology, notably as a therapeutic target. A systematic review was conducted by searching digital databases for studies. Based on inclusion and exclusion criteria, ten articles were thoroughly assessed. Emerging evidence links MOAP-1 to bladder cancer chemosensitivity and MOAP-1-dependent chemosensitization of breast cancer mediated by phenylquinazoline derivatives. In addition, apoptosis in breast cancer cells was induced by α-mangostin, a potential therapeutic drug targeting MOAP-1 and BCL-XL interaction. Studies showed MOAP-1's importance in NSCLC, with its upregulation in the cancer cells as a potential treatment. This review also highlights the role of miR-25 as a cellular regulator of MOAP-1 and its implication for MOAP-1-mediated therapeutics. The intricate control of MOAP-1 in cancer highlights the need for more research to understand its function and regulation across cancer types completely. MOAP-1's tumor suppressor activity suggests it could be a therapeutic target, as evidenced by current research findings, which is likely to spur further research into MOAP-1-targeted cancer treatments. This systematic review fills a gap in the literature by bringing together a variety of study findings to promote a deeper understanding of MOAP-1 and its therapeutic potential.


  • Open Access

    Ethnomedicinal Uses, Phytochemistry, and Therapeutic Potentials of Litsea glutinosa (Lour.) C. B. Robinson: A Literature-Based Review

    by Sarmin Jamaddar, António Raposo, Chandan Sarkar, Uttam Kumar Roy, Isaac Moura Araújo, Henrique Douglas Melo Coutinho, Ali Saleh Alkhoshaiban, Hmidan A. Alturki, Ariana Saraiva, Conrado Carrascosa, et al.

    Litsea glutinosa (Lour.) C. B. Robinson, belonging to the family Lauraceae, is a multipurpose and fast-growing evergreen or deciduous tree that has been traditionally used for numerous purposes such as treatment for diarrhea, dysentery, abdominal pain, indigestion, gastroenteritis, edema, traumatic injuries, colds, arthritis, asthma, diabetes, pain relief, and poignant sexual power. This study aimed to summarize the chemical reports, folk values, and phytopharmacological activities of L. glutinosa, based on available information screened from diverse databases. An up-to-date electronic-based search was accomplished to obtain detailed information, with the help of several databases such as Google Scholar, Scopus, SpringerLink, Web of Science, ScienceDirect, ResearchGate, PubMed, ChemSpider, Elsevier, BioMed Central, and the USPTO, CIPO, INPI, Google Patents, and Espacenet, using relevant keywords. Outcomes advocate that, up to the present time, alkaloids, glycosides, and terpenoids are abundant in, and the most bioactive constituents of, this natural plant. Results demonstrated that L. glutinosa has various remarkable biological activities, including antioxidant, anti-inflammatory, anti-microbial, anticancer, antipyretic, anti-diabetic, analgesic, hepatoprotective, and wound-healing activity. One study revealed that L. glutinosa exhibited significant aphrodisiac and anti-infertility activity. Nevertheless, no clinical studies have been cited. Taken together, L. glutinosa may be one of the significant sources of bioactive constituents that could potentially lead to different effective pharmacological activities. On the other hand, future research should focus on clinical studies and several toxicity evaluations, such as sub-chronic toxicity, teratogenicity, and genotoxicity.


  • Open Access

    Type II diabetic patients' satisfaction, medication adherence, and glycemic control after application of pharmacist counselling program

    by Ali Alkhoshaiban, Yahaya Hassan, Mathumalar Loganathan, Mohammad Alomary, Donald E. Morisky, Bader Alawwad

    Background: Health complication with type 2 diabetic mellitus (T2DM) increases as the patient advances in age. This study aims to investigate if the pharmacist counseling program has an impact on patient medication adherence and satisfaction of elderly diabetic patients. Moreover, we aim to investigate the impact of patients’ adherence on HbA1c. Methods: This is a comparative study was carried out in the diabetic clinic in a governmental hospital at King Saud Hospital, Unaizah city, in Sau


  • Open Access

    Knowledge of Pharmacists about Diabetes Mellitus

    by Ali Alkhoshaiban, Ahmad Almeman

    Objective: The aim of this study was to evaluate the knowledge among pharmacists towards DM diagnosis and management. Methods: This was a comparative study that was carried out in the diabetic clinic in a governmental hospital at King Saud Hospital, Unaizah city, in Saudi Arabia, over a period of eight months, starting from June 2015. The study was consists of three phases 1) a pre-test survey for the pharmacist regarding their knowledge on diabetes by using the Michigan Diabetes Knowledge